Title compds. I [X = (un)​substituted phenylene; Y = absent, CO, or CH2; R3 = absent, Ph, NH2, NHMe, etc.; R7 = H or halo; with provisions]​, and their pharmaceutically acceptable salts, are prepd. and disclosed as PARP inhibitors. Thus, e.g., II was prepd. by a multistep procedure (prepn. given)​. Select I were evaluated in PARP inhibition assays, e.g., II demonstrated an IC50 value of between >100 nM to <500 nM.

Preparation of azaindole derivatives for use as PARP inhibitors / G. Giannini, L. Vesci, S. Dallavalle, L. Merlini.

Preparation of azaindole derivatives for use as PARP inhibitors

S. Dallavalle
Penultimo
;
L. Merlini
Ultimo
2015

Abstract

Title compds. I [X = (un)​substituted phenylene; Y = absent, CO, or CH2; R3 = absent, Ph, NH2, NHMe, etc.; R7 = H or halo; with provisions]​, and their pharmaceutically acceptable salts, are prepd. and disclosed as PARP inhibitors. Thus, e.g., II was prepd. by a multistep procedure (prepn. given)​. Select I were evaluated in PARP inhibition assays, e.g., II demonstrated an IC50 value of between >100 nM to <500 nM.
SIGMA TAU INDUSTRIE FARMACEUTICHE RIUNITE
WO2015/011008
PCT/EP2014/065367
29-gen-2015
Settore CHIM/06 - Chimica Organica
Settore CHIM/08 - Chimica Farmaceutica
Preparation of azaindole derivatives for use as PARP inhibitors / G. Giannini, L. Vesci, S. Dallavalle, L. Merlini.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/269139
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact